Exploration of Extracellular Vesicle miRNAs, Targeted mRNAs and Pathways in Prostate Cancer: Relation to Disease Status and Progression.

Puhka, Maija; Thierens, Lisse; Nicorici, Daniel; Forsman, Tarja; Mirtti, Tuomas; Af Hällström, Taija; Serkkola, Elina; Rannikko, Antti

Puhka, Maija; Thierens, Lisse; Nicorici, Daniel; Forsman, Tarja; Mirtti, Tuomas; Af Hällström, Taija; Serkkola, Elina; Rannikko, Antti.

Afiliação

Puhka M; HiPrep and EV Core, Institute for Molecular Medicine Finland FIMM, University of Helsinki, 00290 Helsinki, Finland.
Thierens L; HiPrep and EV Core, Institute for Molecular Medicine Finland FIMM, University of Helsinki, 00290 Helsinki, Finland.
Nicorici D; Orion Pharma, Orion Corporation, 02200 Espoo, Finland.
Forsman T; Orion Pharma, Orion Corporation, 02200 Espoo, Finland.
Mirtti T; Department of Pathology, HUS Diagnostic Centre, Helsinki University Hospital, 00290 Helsinki, Finland.
Af Hällström T; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.
Serkkola E; AstraZeneca, 02600 Espoo, Finland.
Rannikko A; Orion Pharma, Orion Corporation, 02200 Espoo, Finland.

Cancers (Basel) ; 14(3)2022 Jan 21.

Article em En | MEDLINE | ID: mdl-35158801

Palavras-chave

exosomes; extracellular vesicles; messenger RNA; micro RNA; pathway; progression; prostate cancer; sequencing

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Finlândia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google